227 related articles for article (PubMed ID: 16818006)
1. Surgical wait times for patients with urological cancers: a survey of Canadian surgeons.
Fleshner N; Dranitsaris G; Finelli A; Tsihlias J; Bell D; Gleave M;
Can J Urol; 2006 Jun; 13 Suppl 3():3-13. PubMed ID: 16818006
[TBL] [Abstract][Full Text] [Related]
2. Consensus document: recommendations for optimal surgical wait times for patients with urological malignancies.
Canadian Surgical Wait Times (SWAT) Initiative
Can J Urol; 2006 Jun; 13 Suppl 3():62-4. PubMed ID: 16818014
[TBL] [Abstract][Full Text] [Related]
3. Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature.
Bell D; Morash C; Dranitsaris G; Izawa J; Short T; Klotz LH; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():30-6. PubMed ID: 16818010
[TBL] [Abstract][Full Text] [Related]
4. Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature.
Fradet Y; Aprikian A; Dranitsaris G; Siemens R; Tsihlias J; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():37-47. PubMed ID: 16818011
[TBL] [Abstract][Full Text] [Related]
5. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature.
Saad F; Finelli A; Dranitsaris G; Goldenberg L; Bagnell S; Gleave M; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():16-24. PubMed ID: 16818008
[TBL] [Abstract][Full Text] [Related]
6. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature.
Jewett M; Rendon R; Dranitsaris G; Drachenberg D; Tanguay S; Donnelly B; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():54-61. PubMed ID: 16818013
[TBL] [Abstract][Full Text] [Related]
7. The impact of introducing laparoscopic radical prostatectomy on surgical wait times for prostate cancer.
Hamilton RJ; Finelli A
Can J Urol; 2006 Jun; 13 Suppl 3():25-9. PubMed ID: 16818009
[TBL] [Abstract][Full Text] [Related]
8. Ontario wait time strategy.
Hudson AR
Can J Urol; 2006 Jun; 13 Suppl 3():14-5. PubMed ID: 16818007
[TBL] [Abstract][Full Text] [Related]
9. The impact of provider volume on outcomes from urological cancer therapy.
Joudi FN; Konety BR
J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
[TBL] [Abstract][Full Text] [Related]
10. [Urological cancer].
Kato M; Higashihara E
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1255-9. PubMed ID: 16184920
[TBL] [Abstract][Full Text] [Related]
11. [The surgical management of recurrent urological malignancies after primary ablative therapy].
Galiano M; Dugardin F; Rozet F; Cathelineau X; Vallancien G
Bull Cancer; 2004 Nov; 91(11):875-81. PubMed ID: 15582892
[TBL] [Abstract][Full Text] [Related]
12. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; Rouprêt M
World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
[TBL] [Abstract][Full Text] [Related]
13. [Indication and limitation of endoscopic surgery against urological cancer].
Kondo Y; Nishimura T
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1501-5. PubMed ID: 15508440
[TBL] [Abstract][Full Text] [Related]
14. Longer wait times increase overall mortality in patients with bladder cancer.
Kulkarni GS; Urbach DR; Austin PC; Fleshner NE; Laupacis A
J Urol; 2009 Oct; 182(4):1318-24. PubMed ID: 19683272
[TBL] [Abstract][Full Text] [Related]
15. The utility of publicly reported cancer treatment wait time information for patients and health care providers.
Whitton AC; Green E; Evans WK; Fitch M; Golden B; Soman D; Gutierrez E; Holowaty E; Jadad AR
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):218-25. PubMed ID: 19157813
[TBL] [Abstract][Full Text] [Related]
16. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
17. [Laparoscopic surgery in urologic oncology].
Vallancien G; Cathelineau X; Barret E; Rozet F
Bull Acad Natl Med; 2007 Oct; 191(7):1367-73; discussion 1373-4. PubMed ID: 18447058
[TBL] [Abstract][Full Text] [Related]
18. Integrating metastasectomy in the management of advanced urological malignancies-where are we in 2005?
Rasco DW; Assikis V; Marshall F
J Urol; 2006 Nov; 176(5):1921-6. PubMed ID: 17070212
[TBL] [Abstract][Full Text] [Related]
19. Surgical practices for urological tumors: a nation-wide survey in Japan in 2005.
Kawakami S; Kihara K; ;
Int J Urol; 2009 Mar; 16(3):257-62; discussion 262. PubMed ID: 19215318
[TBL] [Abstract][Full Text] [Related]
20. Modeling procedure and surgical times for current procedural terminology-anesthesia-surgeon combinations and evaluation in terms of case-duration prediction and operating room efficiency: a multicenter study.
Stepaniak PS; Heij C; Mannaerts GH; de Quelerij M; de Vries G
Anesth Analg; 2009 Oct; 109(4):1232-45. PubMed ID: 19762753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
